The Navigator Company (NVG) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
4 Aug, 2026Purpose and values
Focus on improving people's quality of life and the planet's future, guided by trust, integrity, innovation, sustainability, and excellence.
Integrated business model and market leadership
Vertically integrated producer of forestry, pulp, paper, tissue, packaging, and bioenergy, with 1.6 Mt annual capacity each for paper and pulp, and 165 kt for tissue.
Over 90% of sales exported to 130 countries; leading positions in European UWF paper and eucalyptus pulp markets.
Resilient business model with diversified products, premium segment focus, and consistent EBITDA margins averaging 24.8% over 14 years.
Operational highlights and expansion
Major production sites in Portugal, Spain, and the UK, with recent acquisition of Accrol expanding UK tissue market presence.
Tissue business now #2 in Iberia and #4 in UK, with 165 kt capacity and strong brand innovation.
Packaging segment growing with gKRAFT™ brand and new molded pulp products targeting plastic substitution.
Latest events from The Navigator Company
- Global leader in pulp, paper, and tissue, excelling in sustainability, innovation, and financial strength.NVG
Investor presentation - Delivers industry-leading margins, strong growth in tissue and packaging, and top ESG performance.NVG
Investor presentation - Record Q1 2024 results, strong market leadership, and ambitious sustainability investments.NVG
Investor presentation - Global leader in pulp, paper, and tissue, driving growth through sustainability and innovation.NVG
Investor presentation - Global leader in sustainable pulp, paper, and tissue, driving growth through innovation and ESG.NVG
Investor presentation - Strong 2024 results with premium focus, diversification, and sustainability-driven growth.NVG
Investor presentation - Pricing recovery, efficiency gains, and ESG investments offset operational headwinds.NVG
Q2 2026 - Tissue and Packaging growth offset profit declines, with resilience amid global volatility.NVG
Q2 2025 - Turnover, EBITDA, and net profit all rose double digits, led by tissue and packaging growth.NVG
Q3 2024